Florian Brand

Florian Brand is CEO of Atai Life Sciences, a German biopharmaceuticals company that is trying to develop new mental health treatments based on novel technology and drugs—notably psilocybin mushrooms and other psychoactive substances whose medical uses have only recently started being taken seriously. Brand, who has a business rather than medical background, delved into the field after witnessing friends and family members struggle to find adequate conventional treatments for their depression and other mental health disorders. Brand notes the need for diverse treatments in the space, and Atai has set up or bought a number of subsidiaries that are each investigating different potential routes. The company hopes to gather a critical mass of data within the next couple of years, and is working with regulators to pave the way for future treatments.

Follow:

Twitter

Instagram